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Abstract 
The British Service Dhaulagiri Research Expedition took place in March-May 2016.  A total 
of 129 personnel took part in the expedition and were invited to consent to a variety of study 
protocols investigating adaptation to high altitudes and diagnosis of altitude illness.  The 
study took place in a remote and inhospitable environment at altitudes up to 5300m. 
This paper gives an overview of the challenges involved, the research protocols investigated 
and the execution of the expedition in Nepal. 
 
  
Introduction 
The UK military runs a programme of adventurous training (AT) with the aims of promoting, 
“through the conduct of arduous outdoor activities with exposure to hardship and danger, the 
Army’s core values, leadership, teamwork and other qualities necessary to enhance the 
Operational effectiveness of all military personnel”.[1]  In a four yearly cycle the single 
Service mountaineering clubs, in rotation, lead a major expedition as an inspirational AT 
activity.  This is usually, but not exclusively, a mountaineering expedition to one of the 
world’s 14 8,000m peaks (located in Nepal and Pakistan).  The 2016 quadrennial trip was a 
Royal Naval lead and the opportunity was taken to mount a significant medical research 
expedition to the Dhaulagiri region of Nepal, the British Services Dhaulagiri Medical 
Research Expedition (BSDMRE) 2016.  The expedition had support of His Royal Highness 
the Duke of York and the Surgeon General. 
We have previously published in this journal on the challenges and opportunities of research 
in high altitude environments and on the potential benefits of AT.[2 3]  This research 
expedition was part of ongoing UK military research and focussed on basic science, 
diagnosis of altitude illness and strategies to enable rapid deployment of troops in a high 
altitude (HA) environment (pre-acclimatisation).   
Funding 
AT is formal, publicly funded military training. Participation in AT is “an integral aspect of 
military training that supports the values and standards of the military thus enhances an 
individual’s ability to withstand the rigours of operations”.[1]  This direct public funding 
contributed around 50% of the costs for each subject which in turn facilitated the relatively 
large numbers for a research expedition.  Research funding was supported by industry 
(Medtronic Reveal Linq devices provided free of charge), public funding through RCDM and 
a grant from the Royal Navy Royal Marines Charity (RNRMC).  It is exceptional for the 
RNMC to support research in this way but a large fundraising event with the support of the 
Duke of York enabled the charity to raise sufficient funds to underwrite the research costs.     
Environment 
For the initial part of the trek of the Dhaulagiri circuit the terrain was at low altitude (although 
daily ascent was considerable) and through hot, humid pasture and rainforest.  From IBC 
onwards the trek followed glaciated terrain around the western and northern aspects of 
Dhaulagiri.  This terrain was dry and hot during the day and cold at night.  Temperatures in 
the Hidden Valley were frequently around -10ºC by night with considerable wind chill.  By 
day temperatures in the direct sun or inside tents could be as high as +30ºC.  Above IBC all 
precipitation fell as snow due to the low temperatures, whereas IBC itself experienced heavy 
afternoon rain storms during the latter part of the expedition.  All research took place in tents, 
there is no hard accommodation on the circuit above IBC, frequently early in the morning to 
take measurements in the starved state.  This placed a great strain on the research teams 
who had to work in extreme temperatures, often clad in one piece down suits! 
Methods 
The pathophysiology of High Altitude (HA) illness remains ill-defined but the rate of Acute 
Mountain Sickness (AMS) among military personnel ascending to HA as part of Adventure 
Training is significant with 34% of those ascending Mount Kenya suffering severe AMS in one 
report.[4] AMS was also a significant cause of Disease Non-Battle Injury (DNBI) during the 
Battle of Taku Ghar in Afghanistan in 2002 with 18 cases of AMS requiring casevac from 
theatre of ops and treatment by 274th FST.[5] The programme of research on the expedition 
was aimed at enhancing our understanding of the pathophysiology of HA exposure and AMS 
and answering some of the questions raised previously in this journal.[6]  The research was a 
collaborative venture between the Royal Centre for Defence Medicine, Leeds Beckett 
University and Oxford University.  The following submissions were made to the MoD Research 
Ethics Committee (MoDREC); 
Protocol 578, Cardiovascular adaptation and recovery in chronic hypoxia. We have 
previously assessed various methods of recording heart rate variability at HA [7] and this 
study aimed to collect data on all the trekking teams, investigating changes in a range of 
physiological variables including heart rate variability, central aortic blood pressures and 
pulmonary artery pressures.  
Protocol 580, Utility of BNP in diagnosing Acute Mountain Sickness (AMS).  We have 
previous published that BNP may have utility in the diagnosis of altitude illness.[8-11]  This 
study aims to recruit subjects who become unwell on expeditions at HA over the next few 
years.  This will enable us to establish whether BNP can be used to discriminate between 
those with AMS or other conditions. 
Protocol 608,  The effects of progressive High Altitude on the development and burden of 
significant cardiac arrhythmias using an implantable Cardiac Monitor (REVEAL Study). This 
study will use a small implantable (into the subcutaneous fat of the upper chest) cardiac 
monitoring device, a “Reveal LINQ” made by Medtronic. This has the capability to record and 
store information about heart rate and rhythm that can then be downloaded to a hard drive for 
subsequent analysis. The marked hypoxaemia that occurs at altitude could be arrythmogenic 
and significant cardiac morbidity is known to occur at HA. This work builds on a smaller study 
using the predecessor to the current Reveal device that suggested significant arrythmias do 
occur at HA.[12] 
Protocol 624  Appetite responses during a high altitude expedition. Very little is known about 
the underlying mechanisms regarding the anorexia and nausea suffered at HA, a topic 
previously reviewed in this journal.[13]  Reductions in appetite contribute to the degradation 
that ultimately impairs performance at HA. This project will investigate nutritional changes at 
HA using food diaries, an assessment of gut hormones involved in appetite regulation and 
the novel use at HA of wearable technology assessing continuous subcutaneous interstitial 
glucose levels.      
Protocol 623  Biomechanical changes in walking gait and balance at altitude. Changes in 
balance may occur at HA and it has been suggested that changes in balance and walking 
style may be related to the development of acute mountain sickness (AMS) and to the 
incidence of falls and accidents on expeditions. This research will examine joint position 
sense, balance and coordination through a series of assessments including video 
assessment of gait and balance using a force platform. 
Protocol 663  Effects of iron status, manipulated using intravenous iron, on cardiopulmonary 
physiology during ascent to very high altitude, assessed using echocardiography and self-
reported functional performance scores.  Exposure to the hypoxia of altitude leads to many 
physiological changes and a key feature is hypoxic pulmonary vasoconstriction (HPV). HPV 
increases pulmonary artery systolic pressure (PASP) and contributes to right ventricular 
strain and exaggerated HPV is a feature of High Altitude Pulmonary Oedema. (HAPE). This 
study intends to use an intravenous iron infusion to optimise iron stores which at sea-level is 
known to attenuate the HPV response to hypoxia.[14]  There has been one previous trial that 
has also shown a reduction in AMS following intravenous iron.[15]  Participants will be 
randomly assigned to iron or placebo and echocardiography will be used to assess their 
PASP in the field, while Lake Louise scores will be used to assess any difference in AMS 
rates. 
Protocol 586  Acclimation and acclimatisation: The effects of Exercise under Normobaric 
(normal pressure) Hypoxic (reduced Fi02) conditions. We have been investigating the utility 
of “pre-acclimatisation” in a hypoxic chamber in order to establish if such exposure can 
improve performance on deployment to HA and reduce HA illness. This protocol will 
compare the effects of 5 days in a normobaric hypoxic chamber at simulated altitudes of 
between 4300 and 4800 m with a control group. Echocardiographic variables, biochemical 
and endocrine markers of physiological stress and indices of respiratory variables 
representing acclimatization will be assessed pre- and post-hypoxic exposure as well as 
during the expedition in order to elucidate any benefit. Additionally, rates of AMS will be 
assessed in the field to see if prior acclimation can reduce the threat from HA illness.  
Protocol  625  Application of Apnoeic training and physiological adaptations to altitude.  
Free-divers expose themselves to periods of apnoea and prepare for this by a relatively 
simple method of “breath-holding”. Apnoea training induces changes that could potentially 
be of benefit at HA, including an increase in haematocrit, haemoglobin, erythropoietin and 
oxygen saturation.[16]  This protocol will employ a 6 week breath hold training programme 
and compare this with a control group. Variables will be assessed in the normobaric hypoxic 
chamber pre-departure at a simulated 5050 m and while on the trek and will include 
assessments of spleen volume, oxygen saturation, haemoglobin, haematocrit, erythropoietin 
and rates of AMS. Both protocol 586 and 625 benefit from access not only to the fixed 
normobaric chamber at Leeds Beckett but also a portable hypoxic chamber purchased with 
a grant from Joint Medical Command via the DMS Research Steering Group.  
Protocols were submitted to the RAF Scientific Advisory Committee(SAC) and subsequently 
MoDREC during 2014 to ensure plenty of lead in time and that projects could be in place 
prior to recruiting participants for the AT activity. The researchers acknowledge the efforts 
and diligence of both the SAC and MODREC, whose input significantly enhanced the 
scientific work proposed.  A recce to the area and limited research conducted during 
February 2015 was hugely useful in finalising research plans and resulted in some limited 
amendments to protocols.   
Participants were all members of HM Forces taking part in an AT exercise and on duty.  
Selection for this expedition was via Defence Instructions and Notices advertising the event, 
advertisement through military climbing clubs and via word of mouth.  Trekking teams were 
selected by individual leaders and not by the overall expedition leadership or Principle 
Investigators.  Climbing teams were selected on the basis of previous climbing experience.  
Once involved in the expedition participants were invited to take part in specific research 
studies.  Participants were invited to participate in studies depending on time availability and 
geographical location before written informed consent was obtained.  Where teams were 
used as controls for an intervention group every effort was made to match military 
backgrounds of individuals to ensure similar levels of fitness. 
All participants received a brief on mountain health including acute mountain sickness (AMS) 
and the military policy of not using prophylactic acetazolamide (Diamox®) in this setting. 
Baseline data was collected in the UK by a suitably qualified researcher before any pre-
acclimatisation training took place.   
On the expedition data was collected by the subjects (daily diaries) and then at three 
research camps established for the duration of the expedition.  These camps were located at 
3600m, Italian base camp (BC), 4600m, Dhaulagiri BC and 5150m in the Hidden Valley.  
These camps had resident staff of two trained researchers (at least one medically qualified 
in each location).  Additional researchers (military or Leeds Beckett staff) accompanied 
specific trekking teams to collect specialist data (continuous glucose measurements, cardiac 
echo, spleen ultrasound and conduct balance testing). 
Climbing teams had background data collected at the time of Reveal LINQ device insertion 
or when enrolled in the iron study.  Any potential subject who could not comply with these 
timings (usually for service reasons) were not included in these studies although data was 
collected for non-intervention studies.  All participants were low altitude dwellers, no trekking 
team members had exposure to >1500m terrestrial altitude in the four weeks prior to the 
studies.  
Research protocols undertaken by the climbers were developed mindful of minimising the 
impact of research data collection when in country.  All team members flew to Kathmandu 
via long haul international flights.  Baseline data was collected the day after arrival or after 4 
days in Kathmandu in the case of the advance party.  This involved recording symptoms, 
SpO2 (Nonin Onyx, Nonin Medical Inc, Plymouth, Minnesota), haemaglobin (Haemocue, 
Haemocue AB, Angelholm, Sweden), cardiac function and pulmonary artery pressures (Vivid 
I, GE Healthcare, Amersham, UK) and was completed by one experienced cardiologist 
blinded to the intervention (in the case of the iron study).  The team then moved to 2750m by 
road, where a further data collection period took place (day 4).  After day 4 all altitude 
changes where accomplished on foot carrying moderate loads (5-10Kg).  Further altitude 
changes are given in table 1.  Climbers completed an individual itinerary depending on self-
declared fitness to continue with the ascent profile and rest days taken as required.  
Subjects recorded daily Lake Louise self-reported scores (LLS), AMSc scores, anxiety 
questionnaires (STAI), SpO2, heart rate and heart rate variability (HRV) via iThlete app.  The 
iThlete app records HRV over a one minute period of timed ventilation (20 breaths) to give a 
number indicating HRV.  The heart rate is recorded onto a smart phone using the phones’ 
microphone and a finger probe.  This number is based on RMSSD of HRV and we have 
recently published the validity of the iThlete app vs. conventional HRV measurement.  HRV 
recording were not blinded and were taken by the individual first thing in the morning, in a 
seated position, before food or caffeine wherever possible.  Decisions regarding individual 
fitness to continue with the itinerary or climb higher were made regardless of HRV reading 
(after consultation with a medical officer who was also unaware of HRV reading where 
necessary).  Borg RPE for the “sessional exertion” each day was recorded each evening and 
subjects asked to record their perception as to how hard the hardest bout of exercise that 
day had been (on a scale of 6-20). Reveal Linq cardiac rhythm monitors were inserted into 
members of the climbing team (Reveal LINQ, Medtronic, Dublin, Ireland).  These devices 
were inserted by a consultant cardiologist (CB) at Poole Hospital during January 2016. The 
device automatically records any tachycardia, bradycardia or arrhythmia.  Baseline data was 
collected automatically via the Carelink system in the UK and downloaded every few days 
using a larger programmer device in Nepal.  
 
Day Sleeping altitude Activity (evening 
location) 
 
0 1400m Arrive Kathmandu  
1 1400m Kathmandu – baseline data collected 
2 848 m Beni 
3 2679m Move to Marpha by vehicle  
4 2679 Marpha, subjects free to do own trekking 
acclimatisation 
5 3720m Trek Alu Bari Lower Camp, 3650m, o/n 
camp 
6 3720m Alu Bari Lower Camp, 3650m, 
Acclimatisation day. 
7 4150m Trek Yak Kharta 
8 4150m Yak Kharta, 4600m, acclimatisation day, 
o/n camp   
9 4150m Yak Kharta, 4600m, acclimatisation day, 
o/n camp   
10 5140m Trek Hidden Valley 4975m (via Dhampus 
Pass 5250m) 
10  Hidden Valley, 4975m, acclimatisation day, 
11-24  Hidden valley basecamp for attempts on 
Dhampus peak 6035m and Tukuche peak 
6800m – individual itineraries. 
25 4800m Team reduces to 12 and move to Dhaulagiri 
BC 
26 - 50  Dhaulagiri BC – individual itineraries. 
Altitude of 7500m achieved by 5 team 
members. 
51  Trek to Hidden 
Valley 
 
52  Trek to Marpha 
  Rest Marpha  
  Rest Marpha  
  Drive to Pokhara  
  Drive to Kathmandu  
  Fly to UK  
Table 1.  Climbing team itinerary 
Trekking teams were invited to take part in studies (580, 578, 586, 623, 624, 625).  
Recruitment and interest in the studies was high. 
Trekkers all arrived in Kathmandu by long haul air travel and travelled by road to 1123m 
before attempting a trek of the Dhaulagiri circuit.  Each team was accompanied by a medical 
officer who advised on any changes in itinerary based on team or individual acclimatisation.  
Further medical support was available at 3600m, 4650m and 5140m.  The itinerary (table 2) 
and altitude profile (fig 1) are below.  Changes of itinerary where made as necessary when 
trekkers showed signs of acute mountain sickness.   Trekkers completed a daily recording of 
Lake Louise self-reported scores, AMSc scores, STAI, SpO2, heart rate.  At 3600m, 4650m 
and 5140m heart rate variability was recorded via a “check my heart” HRM device.  This was 
a conventional single lead ECG and data were downloaded to a laptop to be analysed offline 
by a cardiologist who was blinded to the individuals’ performance and LLS.  
 Table 2.  Trekking team itinerary 
 Activity Sleeping altitude 
Day 1 Fly from UK.  
Day 2 Arrive Kathmandu  
Day 3 In Kathmandu. Sightseeing 
tour. 
 
Day 4 Drive Beni via Pokhara  
Day 5 Drive Darbang and trek 
Riverside 
 
Day 6 Trek Jugepani 1456m 
Day 7 Trek Bagar 2017m 
Day 8 Trek Doban 2430m 
Day 9 Trek Sallagari 3107m 
Day 10 Trek Italian BC 3619m 
Day 11 Rest day at Italian BC  
Day 12 Trek to Japanese Camp or 
Upper Swiss BC 
4072m 
Day 13 Trek Dhaulagiri Lower BC 4600m 
Day 14 Rest Day, Dhaulagiri 
Lower BC  
4600m 
Day 15 Trek Hidden Valley 5140m 
Day 16  Rest day at Hidden Valley.  
Results 
129 military participants took part in the expedition including 7 research/medical staff. Two 
trekkers were removed from the trail with minor illness before exposure to any significant 
altitude.  Three trekkers descended earlier than planned via Italian BC from higher on the 
trail.  Four trekkers required extraction from the Hidden Valley by helicopter.  One member of 
the HADT withdrew on day 4 of the trek due to non-altitude related illness.  22 of the 
remaining members of the HADT and main team reached 6035m and five reached 7550m 
on Dhaulagiri. 
Acute mountain sickness (AMS) was diagnosed by the Lake Louise or AMSc Scores from 
the daily symptoms scores recorded.  Subjects were included in analysis with a positive 
diagnosis of AMS if they took drugs to aid acclimatisation or if they were evacuated by 
helicopter with no symptom scores recorded.  
Data collection was completed well with relatively few missed data collection points.  The 
Dhaulagiri circuit is extremely remote and the satellite communication between camps was 
patchy which reduced the ability to trouble shoot and provide rigorous oversight.   
Conclusion 
The BSDMRE 2016 provided a unique opportunity to perform high quality research projects 
in the most challenging and austere of situations.  The combination of AT and research on 
an exercise of this scale was a novel and organisational challenging but will result in 
significant and militarily relevant outputs. 
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